Beilai Bio

Irvine, United States

Beilai Bio biopharmaceutical company focusing on the development of stem cell therapeutics for different diseases

$47.1M raised

Apr 2022

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Beilai Bio raised?

Beilai Bio has raised $47.1M in total funding. The most recent round was Series B. The last funding was announced in April 2022.

Who are Beilai Bio's investors?

Beilai Bio's investors include DT Capital Partners, SDIC Venture Capital, Huajin Capital, Nanjing Jiangbei New Area Industrial Investment Group.

Where is Beilai Bio headquartered?

Beilai Bio is headquartered in Irvine, United States.

What does Beilai Bio do?

Beilai Bio biopharmaceutical company focusing on the development of stem cell therapeutics for different diseases

What stage is Beilai Bio at?

Beilai Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 15, 2022.

MLA

"Beilai Bio — Funding & Investors." VCBacked, April 15, 2022, https://www.vcbacked.co/company/beilai-bio. Accessed July 2, 2026.

APA

VCBacked. (2022). Beilai Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/beilai-bio

Wikipedia (cite web)

{{cite web |title=Beilai Bio — Funding & Investors |url=https://www.vcbacked.co/company/beilai-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 15, 2022.